These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5031995)

  • 1. Immunological studies of collagens modified by reaction with hydralazine.
    Paz MA; Seifter S
    Am J Med Sci; 1972 Apr; 263(4):281-90. PubMed ID: 5031995
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.
    Yamauchi Y; Litwin A; Adams L; Zimmer H; Hess EV
    J Clin Invest; 1975 Oct; 56(4):958-69. PubMed ID: 808562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IMMUNOLOGICAL ASPECTS OF COLLAGEN DISEASES].
    Tidsskr Nor Laegeforen; 1964 Jan; 84():63-7. PubMed ID: 14101802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the pathogenesis of hydralazine-induced lupus erythematosus-like syndrome (author's transl)].
    Yamauchi Y
    Ryumachi; 1979 Apr; 19(2):88-104. PubMed ID: 312536
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulins G, A, and M in systemic lupus erythematosus. Relationship to serum complement titer, latex titer, antinuclear antibody, and manifestations of clinical disease.
    Cass RM; Mongan ES; Jacox RF; Vaughan JH
    Ann Intern Med; 1968 Oct; 69(4):749-56. PubMed ID: 4176198
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.
    ten Veen JH
    Clin Exp Immunol; 1973 Nov; 15(3):375-84. PubMed ID: 4587506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
    Lester RS; Burnham TK; Fine G; Murray K
    Arch Dermatol; 1967 Jul; 96(1):1-10. PubMed ID: 5298279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic aspects of humoral immunity reactions to collagen in man and animals. III. An analysis of the sexual dimorphism of the levels of autoantibodies to collagen type I in systemic lupus erythematosus patients and their modifications in ontogeny].
    Lil'in ET; Nesvizhskiĭ IuV; Folomeev MIu
    Genetika; 1986 Jan; 22(1):153-7. PubMed ID: 3949156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.
    Alarcón-Segovia D; Fishbein E; Betancourt VM
    Clin Exp Immunol; 1969 Oct; 5(4):429-37. PubMed ID: 5359961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 12. [ERYTHEMATOSUS AND AUTOIMMUNITY].
    YAMAGUCHI S; KOMIYA M
    Arerugi; 1964 May; 13():329-34. PubMed ID: 14148061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs that induce systemic lupus erythematosus inhibit complement component C4.
    Sim E; Gill EW; Sim RB
    Lancet; 1984 Aug; 2(8400):422-4. PubMed ID: 6147500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.
    Nässberger L; Sjöholm AG; Jonsson H; Sturfelt G; Akesson A
    Clin Exp Immunol; 1990 Sep; 81(3):380-3. PubMed ID: 2168822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus.
    Khan MA; Dixit K; Moinuddin ; Arif Z; Alam K
    Biochimie; 2014 Feb; 97():104-13. PubMed ID: 24113317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced systemic lupus erythematosus (author's transl)].
    Schubothe H; Maas D
    Immun Infekt; 1977 Aug; 5(4):142-56. PubMed ID: 914314
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of the spontaneous humoral immunity reactions to collagen type I in systemic lupus erythematosus patients].
    Nesvizhskiĭ IuV; Solov'ev SK; Panasiuk AF
    Ter Arkh; 1986; 58(12):84-7. PubMed ID: 3824222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotypic cross-reactions of monoclonal human lupus autoantibodies.
    Shoenfeld Y; Isenberg DA; Rauch J; Madaio MP; Stollar BD; Schwartz RS
    J Exp Med; 1983 Sep; 158(3):718-30. PubMed ID: 6886627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.